Monoclonal antibody capable of neutralising CHIKV replication and can detect infection of cells.
| Institute |
|---|
| A*STAR Accelerate Technologies Pte Ltd |
| Cat. #: | 153198 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Microbiology |
| Application: | ELISA ; IHC ; Fn ; WB |
| Target: | N218 epitope on E2 protein of CHIKV |
| Reactivity: | Virus |
| Clone: | 3E7b |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Lam et al. 2015. MAbs. 7(6):1178-1194. PMID: 26305993. |
| Alternate name: | Chikungunya virus; Chikungunya virus antibody |
|---|---|
| Product description: | Anti-CHIKV [3E7b] binds strongly to the native CHIKV surface. This monoclonal antibody is also capable of detecting infection of cells. Chikungunya virus (CHIKV) is an alphavirus known to cause severe polyarthritis and polyarthralgia. CHIKV is transmitted to humans by mosquito vectors, primarily Aedes aegypti and Aedes albopictus. 3E7b potently neutralises CHIKV replication. Additionally, Anti-CHIKV [3E7b] protected mice from CHIKV disease when administered prior to CHIKV infection. |
| Conjugation: | Unconjugated |
| Isotype: | IgM |
| Immunogen: | Live chikungunya virus |
| Immunogen Uniprot ID: | Q8JUX5 |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Chikungunya virus (CHIKV) is an alphavirus which causes febrile illness with severe polyarthralgia, known to be transmitted to humans by mosquito vectors, primarily Aedes aegypti and A. albopictus. Symptoms include high fever, asthenia, chills, headache, diarrhoea, vomiting and rash. Since the re-emergence of CHIKV in La Reunion, epidemic outbreaks of CHIKV infection have been reported globally and CHIKV is now considered endemic in 34 countries across Europe, Australia, Asia and Africa. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Lam et al. 2015. MAbs. 7(6):1178-1194. PMID: 26305993. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.